September 18th, 2013
•Receptor tyrosine kinases are ectopically expressed in many cancers and have been identified as therapeutic targets in acute leukemia. This manuscript describes an efficient strategy for pre-clinical evaluation of tyrosine kinase inhibitors for the treatment of acute leukemia.
Tags
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved